The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover
Condition: Erosive Osteoarthritis Intervention: Drug: Alendronate Effervescent Oral Tablet Sponsors: University Hospital, Ghent; Amgen; EffRx Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials